Literature DB >> 15079009

Stimulation of STN impairs aspects of cognitive control in PD.

T Hershey1, F J Revilla, A Wernle, P Schneider Gibson, J L Dowling, J S Perlmutter.   

Abstract

OBJECTIVE: To test the hypothesis that subthalamic nucleus (STN) stimulation in Parkinson disease (PD) patients affects working memory and response inhibition performance, particularly under conditions of high demand on cognitive control.
METHODS: To test this hypothesis, spatial working memory (spatial delayed response [SDR]) and response inhibition (Go-No-Go [GNG]) tasks requiring varying levels of cognitive control were administered to patients with PD with previously implanted bilateral STN stimulators (n = 24). Patients did not take PD medications overnight. Data were collected while bilateral stimulators were on and off, counterbalancing the order across subjects.
RESULTS: On the SDR task, STN stimulation decreased patients' working memory performance under a high but not low memory load condition (effect of stimulator condition on high load only and condition x load interaction, p < 0.05). On the GNG task, STN stimulation reduced discriminability on a high but not medium inhibition condition (effect of stimulator condition on high inhibition level only, p = 0.05; condition x inhibition level interaction, p = 0.07).
CONCLUSION: STN stimulation reduces working memory and response inhibition performance under conditions of greater challenge to cognitive control despite significant improvement of motor function.

Entities:  

Mesh:

Year:  2004        PMID: 15079009     DOI: 10.1212/01.wnl.0000118202.19098.10

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  65 in total

1.  Mapping Go-No-Go performance within the subthalamic nucleus region.

Authors:  Tamara Hershey; Meghan C Campbell; Tom O Videen; Heather M Lugar; Patrick M Weaver; Johanna Hartlein; Morvarid Karimi; Samer D Tabbal; Joel S Perlmutter
Journal:  Brain       Date:  2010-09-20       Impact factor: 13.501

Review 2.  A fronto-striato-subthalamic-pallidal network for goal-directed and habitual inhibition.

Authors:  Marjan Jahanshahi; Ignacio Obeso; John C Rothwell; José A Obeso
Journal:  Nat Rev Neurosci       Date:  2015-11-04       Impact factor: 34.870

3.  Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?

Authors:  Rupam Borgohain; Rukmini Mridula Kandadai; Afshan Jabeen; Meena A Kannikannan
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

4.  Neural correlates of STN DBS-induced cognitive variability in Parkinson disease.

Authors:  M C Campbell; M Karimi; P M Weaver; J Wu; D C Perantie; N A Golchin; S D Tabbal; J S Perlmutter; T Hershey
Journal:  Neuropsychologia       Date:  2008-07-19       Impact factor: 3.139

5.  Bilateral subthalamic stimulation impairs cognitive-motor performance in Parkinson's disease patients.

Authors:  Jay L Alberts; Claudia Voelcker-Rehage; Katie Hallahan; Megan Vitek; Rashi Bamzai; Jerrold L Vitek
Journal:  Brain       Date:  2008-10-07       Impact factor: 13.501

Review 6.  Impulsivity and Parkinson's disease: more than just disinhibition.

Authors:  Francesca Antonelli; Nicola Ray; Antonio P Strafella
Journal:  J Neurol Sci       Date:  2011-06-17       Impact factor: 3.181

7.  Decreased response inhibition in middle-aged male patients with type 2 diabetes.

Authors:  Kaya T Ishizawa; Hiroaki Kumano; Atsushi Sato; Hiroshi Sakura; Yasuhiko Iwamoto
Journal:  Biopsychosoc Med       Date:  2010-02-11

Review 8.  The role of the subthalamic nucleus in cognition.

Authors:  David B Weintraub; Kareem A Zaghloul
Journal:  Rev Neurosci       Date:  2013       Impact factor: 4.353

9.  Automatic and controlled response inhibition: associative learning in the go/no-go and stop-signal paradigms.

Authors:  Frederick Verbruggen; Gordon D Logan
Journal:  J Exp Psychol Gen       Date:  2008-11

10.  Cognitive declines one year after unilateral deep brain stimulation surgery in Parkinson's disease: a controlled study using reliable change.

Authors:  Laura B Zahodne; Michael S Okun; Kelly D Foote; Hubert H Fernandez; Ramon L Rodriguez; Lindsey Kirsch-Darrow; Dawn Bowers
Journal:  Clin Neuropsychol       Date:  2008-09-23       Impact factor: 3.535

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.